Related Experiment Video
Updated: Jun 4, 2026
Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
Published on: August 25, 2017
Systemic Delivery of aTransgene in Intact Animals by a Retroviral Vector
M J Katovich1, H W Wang, C H Gelband
1Department of Pharmacodynamics, University of Florida, Gainesville, FL.
Insights
Essential hypertension, a chronic cardiovascular disease affecting millions, involves sustained high blood pressure (BP). New treatments are needed because current daily medications don't cure hypertension and compliance is a major issue.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
Background:
- Essential hypertension is a widespread chronic cardiovascular disease impacting over 50 million Americans.
- Characterized by sustained elevated blood pressure (BP), it poses significant risks to major organs like the heart, kidneys, and brain if left untreated.
Purpose of the Study:
- To highlight the critical need for more effective therapeutic interventions for essential hypertension.
- To address the challenges in managing this asymptomatic disease, including treatment compliance and the lack of curative agents.
Main Methods:
- This abstract discusses the pathophysiology and consequences of essential hypertension.
- It reviews current treatment limitations, focusing on daily pharmacological management and the absence of a cure.
Main Results:
- Untreated hypertension leads to severe cardiovascular events such as myocardial infarction, heart failure, stroke, and renal failure.
- Current daily BP-controlling medications do not offer a cure and face compliance challenges.
Conclusions:
- There is a significant unmet need for novel and more effective therapeutic strategies to manage essential hypertension.
- Advanced interventions are required to mitigate the long-term cardiovascular sequelae and improve patient outcomes.
Abstract:
Essential hypertension is a chronic cardiovascular disease that effects over 50 million people in the United States. It is a complex pathophysiological state that is primarily characterized by a sustained elevation in blood pressure (BP). If untreated, this chronically elevated BP can affect major target organs of the body including the heart, kidney, brain, and vascular system. As a consequence of the sustained high BP, there is an increased risk of mortality and morbidity that is characterized by myocardial infarction, congestive heart failure, stroke, end-stage renal failure, and peripheral vascular disease (1-3). Because hypertension is basically an asymptomatic disease, it confounds effective treatment and makes compliance a major issue in the treatment of this disease. Pharmacological agents currently utilized have to be administered daily in an attempt to control BP, and there are no agents available to cure essential hypertension. Thus, more effective therapeutic intervention is required in order to have a significant impact in alleviating this chronic disease and its lethal cardiovascular sequel.
